The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice.

AIMS Rupture of advanced atherosclerotic plaques initiates platelet activation and aggregation as subendothelial collagen is exposed. Platelet collagen receptor glycoprotein VI (GPVI) was found to bind preferentially to the core region of human plaques. Consequently, platelets contribute to inflammatory processes and trigger atherosclerotic lesion progression. In this study, we examined binding of soluble platelet collagen receptor GPVI-Fc to atherosclerotic lesions and its effect on platelet-triggered athero-progression and neointima formation after wire-induced carotid injury. METHODS AND RESULTS For binding studies after ligation-induced arterial injury, the left common carotid artery of C57BL/6J mice was ligated. For binding studies at spontaneously formed atherosclerotic lesion sites, Apolipoprotein E-deficient (ApoE(-/-)) mice were fed a 0.25% cholesterol diet over 16 weeks. Binding of [(124)I]GPVI-Fc was monitored by autoradiography 48 h after intravenous injection and by immunostaining. To study the effect of GPVI-Fc on neointima formation vs. control-Fc, a wire-induced injury of the left A. carotis communis of ApoE(-/-)-mice was performed. Mice were treated intraperitoneally with GPVI-Fc for 8 days and neointima formation was assessed 4 weeks after intervention. [(124)I]GPVI-Fc preferentially bound to injury sites after carotid ligation in C57BL/6J mice and to lipid-rich atherosclerotic lesions of the carotid artery and aortic arch in uninjured ApoE(-/-)-mice. Histological examinations of wire-injured carotid arteries showed that neointima formation was significantly reduced in GPVI-Fc-treated ApoE(-/-) mice compared to ApoE(-/-) mice receiving control-Fc (P < 0.05). CONCLUSION GPVI-Fc preferentially bound to sites of vascular injury and was able to inhibit neointima formation after wire-induced vascular injury in ApoE(-/-) mice. Thus, soluble GPVI-Fc might be also a promising compound to attenuate lesion progression after plaque rupture.

[1]  X. Cheng,et al.  A Simple Method of Plaque Rupture Induction in Apolipoprotein E–Deficient Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Gawaz,et al.  Platelets in inflammation and atherogenesis. , 2005, The Journal of clinical investigation.

[3]  M. Gawaz,et al.  A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.

[4]  N. Plesnila,et al.  Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia: An In Vivo Study in Mice Lacking Glycoprotein IIb , 2005, Circulation.

[5]  S. Watson,et al.  Platelet-collagen interaction: is GPVI the central receptor? , 2003, Blood.

[6]  B. Nieswandt,et al.  Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. , 2005, Blood.

[7]  P. Nastalek,et al.  Mouse models of experimental atherosclerosis. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[8]  L. A. Feeney,et al.  Human platelet glycoprotein VI function is antagonized by monoclonal antibody‐derived Fab fragments , 2003, Journal of thrombosis and haemostasis : JTH.

[9]  M. Schwaiger,et al.  Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. , 2000 .

[11]  G. Angelini,et al.  Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E–Knockout Mouse: Model Characterization and Effects of Pravastatin Treatment , 2005, Circulation.

[12]  U. Heinzmann,et al.  A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo , 2003, The Journal of experimental medicine.

[13]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  Zaverio M. Ruggeri,et al.  Platelets in atherothrombosis , 2002, Nature Medicine.

[15]  M. Majesky.  Mouse model for atherosclerotic plaque rupture. , 2002, Circulation.

[16]  U. Heinzmann,et al.  Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[18]  B. Nieswandt,et al.  Expression and Function of the Mouse Collagen Receptor Glycoprotein VI Is Strictly Dependent on Its Association with the FcRγ Chain* , 2000, The Journal of Biological Chemistry.

[19]  M. Schwaiger,et al.  Non-invasive imaging of glycoprotein VI binding to injured arterial lesions , 2005, Thrombosis and Haemostasis.

[20]  C. Napoli,et al.  Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E‐deficient and LDL receptor‐deficient mice , 2001, The Journal of pathology.

[21]  Jason L. Johnson,et al.  Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. , 2001, Atherosclerosis.

[22]  S. Watson,et al.  Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ‐chain , 1997 .

[23]  S. Schwartz,et al.  Animal models of spontaneous plaque rupture: The holy grail of experimental atherosclerosis research , 2002, Current atherosclerosis reports.

[24]  T. Wells,et al.  The Platelet Collagen Receptor Glycoprotein VI Is a Member of the Immunoglobulin Superfamily Closely Related to FcαR and the Natural Killer Receptors* , 1999, The Journal of Biological Chemistry.